AJTMH Transactions of the Royal Society of Tropical Medicine and Hygiene
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 43(5), 1990, pp. 506-515
Copyright © 1990 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ammann, R. W.
Right arrow Articles by Eckert, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ammann, R. W.
Right arrow Articles by Eckert, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MEBENDAZOLE

Recurrence Rate after Discontinuation of Long-Term Mebendazole Therapy in Alveolar Echinococcosis (Preliminary Results)

Rudolf W. Ammann, Regula Hirsbrunner, Jacques Cotting, Ursula Steiger, Patrick Jacquier AND Johannes Eckert
Gastroenterology Service, University Hospital, Zurich, Switzerland; Institute of Clinical Pharmacology, University of Berne, Berne, Switzerland; Institute of Parasitology, University of Zurich, Zurich, Switzerland

The recurrence rate was investigated in 19 patients with non-resectable alveolar echinococcosis after discontinuation of a long-term therapy with mebendazole (average treatment 4.3 years). A control group consisted of 14 patients who underwent radical surgery and finished a course of prophylactic postoperative mebendazole treatment of 2 years. In the controls, no recurrence was observed after a post-therapy period averaging 3.5 years. In contrast, recurrence occurred in 7/19 patients (37%) with non-resectable alveolar echinococcosis an average of 1.6 years after discontinuation of the long-term mebendazole therapy. The absence of clinically detectable recurrence in the remaining 12 patients seems to be due either to spontaneous inactivation of alveolar echinococcosis preceding chemotherapy or too short post-therapy surveillance. The patients with recurrence responded favorably to reintroduction of chemotherapy. The data indicate that mebendazole therapy is parasitostatic rather than parasiticidal.




This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
S. Reuter, B. Manfras, M. Merkle, G. Harter, and P. Kern
In Vitro Activities of Itraconazole, Methiazole, and Nitazoxanide versus Echinococcus multilocularis Larvae.
Antimicrob. Agents Chemother., September 1, 2006; 50(9): 2966 - 2970.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
A. Lowichik and A. J. Ruff
Topical Review: Parasitic Infections of the Central Nervous System in Children. Part III: Space-Occupying Lesions
J Child Neurol, May 1, 1995; 10(3): 177 - 190.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American Society of Tropical Medicine and Hygiene.